Hiramatsu, Hidefumi http://orcid.org/0000-0003-3136-5670
Adachi, Souichi
Umeda, Katsutsugu
Kato, Itaru
Eldjerou, Lamis
Agostinho, Andrea Chassot
Natsume, Kazuto
Tokushige, Kota
Watanabe, Yoko
Grupp, Stephan A.
Funding for this research was provided by:
Novartis Pharma K.K
Novartis Pharmaceuticals Corporation
Article History
Received: 18 June 2019
Revised: 24 October 2019
Accepted: 29 October 2019
First Online: 11 November 2019
Compliance with ethical standards
:
: IK reports research Grants from Novartis. SAG has received research and/or clinical trial support from Novartis, Servier and Kite. SAG reports consulting, member of study steering committees, or scientific/clinical advisory boards: Novartis, Cellectis, Adaptimmune, Eureka, TCR2, Juno, GlaxoSmithKline, Vertex, Cure Genetics, Humanigen, and Roche. LE, ACA, KN, KT, and YW are employees of Novartis. All other authors declare no competing interests.